These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 7835899

  • 1. A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families.
    Marsh DJ, Robinson BG, Andrew S, Richardson AL, Pojer R, Schnitzler M, Mulligan LM, Hyland VJ.
    Genomics; 1994 Sep 15; 23(2):477-9. PubMed ID: 7835899
    [Abstract] [Full Text] [Related]

  • 2. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
    Prazeres HJ, Rodrigues F, Figueiredo P, Naidenov P, Soares P, Bugalho MJ, Lacerda M, Campos B, Martins TC.
    Clin Endocrinol (Oxf); 2006 Jun 15; 64(6):659-66. PubMed ID: 16712668
    [Abstract] [Full Text] [Related]

  • 3. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
    Zhou Y, Zhao Y, Cui B, Gu L, Zhu S, Li J, Liu J, Yin M, Zhao T, Yin Z, Yu C, Chen C, Wang L, Xiao B, Hong J, Zhang Y, Tang Z, Wang S, Li X, Ning G.
    Clin Endocrinol (Oxf); 2007 Oct 15; 67(4):570-6. PubMed ID: 17573899
    [Abstract] [Full Text] [Related]

  • 4. RET mutations in exons 13 and 14 of FMTC patients.
    Bolino A, Schuffenecker I, Luo Y, Seri M, Silengo M, Tocco T, Chabrier G, Houdent C, Murat A, Schlumberger M.
    Oncogene; 1995 Jun 15; 10(12):2415-9. PubMed ID: 7784092
    [Abstract] [Full Text] [Related]

  • 5. A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening.
    Kaldrymides P, Mytakidis N, Anagnostopoulos T, Vassiliou M, Tertipi A, Zahariou M, Rampias T, Koutsodontis G, Konstantopoulou I, Ladopoulou A, Bei T, Yannoukakos D.
    Clin Endocrinol (Oxf); 2006 May 15; 64(5):561-6. PubMed ID: 16649977
    [Abstract] [Full Text] [Related]

  • 6. [Genetic analysis of RET mutations in families with multiple endocrine neoplasia type II in the community of Murcia].
    Pomares Gómez FJ, Bernabé Espinosa MJ, Matías-Guiu Guía X, Rodríguez González JM, Soriano Palao J, Sola Pérez J, Carbonell Meseguer P, Parrilla Paricio P, Tébar Massó FJ.
    Med Clin (Barc); 1999 May 15; 112(17):646-50. PubMed ID: 10374185
    [Abstract] [Full Text] [Related]

  • 7. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
    Moore SW, Appfelstaedt J, Zaahl MG.
    J Pediatr Surg; 2007 Feb 15; 42(2):326-32. PubMed ID: 17270543
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mutation analysis of the RET proto-oncogene in Dutch families with MEN 2A, MEN 2B and FMTC: two novel mutations and one de novo mutation for MEN 2A.
    Landsvater RM, Jansen RP, Hofstra RM, Buys CH, Lips CJ, Ploos van Amstel HK.
    Hum Genet; 1996 Jan 15; 97(1):11-4. PubMed ID: 8557249
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic.
    Jindrichová S, Vcelák J, Vlcek P, Neradilová M, Nemec J, Bendlová B.
    J Endocrinol; 2004 Nov 15; 183(2):257-65. PubMed ID: 15531714
    [Abstract] [Full Text] [Related]

  • 14. Mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A (Sipple's syndrome).
    Oishi S, Sato T, Takiguchi-Shirahama S, Nakamura Y.
    Endocr J; 1995 Aug 15; 42(4):527-36. PubMed ID: 8556060
    [Abstract] [Full Text] [Related]

  • 15. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report.
    Menon MM, Simha MR.
    Indian J Pathol Microbiol; 2005 Apr 15; 48(2):161-5. PubMed ID: 16758654
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
    Kinlaw WB, Scott SM, Maue RA, Memoli VA, Harris RD, Daniels GH, Porter DM, Belloni DR, Spooner ET, Ernesti MM, Noll WW.
    Clin Endocrinol (Oxf); 2005 Dec 15; 63(6):676-82. PubMed ID: 16343103
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mutational analysis of the RET proto-oncogene in 71 Japanese patients with medullary thyroid carcinoma.
    Shirahama S, Ogura K, Takami H, Ito K, Tohsen T, Miyauchi A, Nakamura Y.
    J Hum Genet; 1998 Dec 15; 43(2):101-6. PubMed ID: 9621513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.